nicotine has been researched along with sr141716 in 44 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 33 (75.00) | 29.6817 |
2010's | 11 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Cohen, C; Perrault, G; Soubrié, P; Steinberg, R; Voltz, C | 1 |
Cohen, C; Griebel, G; Perrault, G; Soubrié, P | 1 |
Goldberg, SR; Le Foll, B | 1 |
De Vries, TJ; de Vries, W; Janssen, MC; Schoffelmeer, AN | 1 |
Forget, B; Hamon, M; Thiébot, MH | 1 |
Camarelles Guillem, F | 1 |
Borel, ML; Guevel-Jointret, AL; Mansourati, J; Munier, S | 1 |
Aso, E; Balerio, GN; Maldonado, R | 1 |
Corelli, RL; Hudmon, KS | 1 |
Barthélémy, S; Forget, B; Hamon, M; Saurini, F; Thiébot, MH | 1 |
Bumgarner, DM; Miller, DK; Putnam, WC; Rodvelt, KR | 1 |
González-Cuevas, G; López-Moreno, JA; Navarro, M | 1 |
Bura, SA; Castañé, A; Ledent, C; Maldonado, R; Valverde, O | 1 |
Frishman, WH | 1 |
Cohen, C; Griebel, G; Kodas, E; Louis, C | 1 |
Calabro, S; Kelsey, JE | 1 |
Cahill, K; Lancaster, T; Stead, L | 1 |
Wonnacott, S | 1 |
Damaj, MI; Lichtman, AH; Martin, BR; Merritt, LL; Walters, C | 1 |
Aubin, HJ; Forget, B; Goldberg, SR; Le Foll, B | 1 |
Buchhalter, AR; Fant, RV; Henningfield, JE | 1 |
De Vries, TJ; de Vries, W; Diergaarde, L; Raasø, H; Schoffelmeer, AN | 1 |
Goldberg, SR; Luchicchi, A; Melis, M; Muntoni, AL; Pillolla, G; Pistis, M; Yasar, S | 1 |
Chang, Y; Dale, LC; Gonzales, D; Lawrence, D; Rigotti, NA | 1 |
Aveyard, P; Hajek, P; Inglis, J; Parsons, AC; Shraim, M | 1 |
Kwiatkowska, M; Limebeer, CL; Litt, DL; Parker, LA; Piomelli, D; Rock, EM | 1 |
Biala, G; Budzynska, B; Staniak, N | 1 |
Bushell, K; Huffman, JW; Martin, BR; Vann, RE; Warner, JA; Wiley, JL | 1 |
Coen, KM; Forget, B; Le Foll, B | 1 |
Bevins, RA; Lyford, GD; Murray, JE; Wells, NR | 1 |
Deissenrieder, F; Groneberg, D; Kusma, B; Mache, S; Quarcoo, D; Welte, T | 1 |
Biala, G; Budzynska, B; Kruk, M | 1 |
Baarendse, PJ; Trezza, V; Vanderschuren, LJ | 1 |
Bhat, A; Crain, D | 1 |
Coen, KM; Gamaleddin, I; Goldberg, SR; Le Foll, B; Makryannis, A; Vemuri, K; Wertheim, C; Zhu, AZ | 1 |
Fang, Q; He, YY; Li, FQ; Li, YQ; Liu, JF; Lu, L; Wang, JS; Xue, YX | 1 |
Lecca, S; Luchicchi, A; Melis, M; Muntoni, AL; Pistis, M | 1 |
Goldberg, SR; Justinova, Z; Makriyannis, A; Redhi, GH; Scherma, M; Schindler, CW; Vadivel, SK | 1 |
Forget, B; Gamaleddin, I; Goldberg, SR; Guranda, M; Le Foll, B | 1 |
Bergman, J; Goldberg, SR; Justinova, Z; Le Foll, B; Makriyannis, A; Redhi, GH; Schindler, CW; Vemuri, K | 1 |
Berrendero, F; Busquets-Garcia, A; de la Torre, R; Di Marzo, V; Flores, Á; Maldonado, R; Marsicano, G; Ozaita, A; Pastor, A; Plaza-Zabala, A; Saravia, R | 1 |
7 review(s) available for nicotine and sr141716
Article | Year |
---|---|
[Medications in smoking cessation].
Topics: Administration, Cutaneous; Adult; Antidepressive Agents, Second-Generation; Bupropion; Cannabinoid Receptor Antagonists; Cannabinoids; Central Nervous System Stimulants; Chewing Gum; Child; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Piperidines; Polymethacrylic Acids; Polyvinyls; Pyrazoles; Rimonabant; Smoking Cessation; Surveys and Questionnaires; Time Factors; Tobacco Use Cessation Devices | 2005 |
Pharmacologic interventions for smoking cessation.
Topics: Administration, Cutaneous; Administration, Inhalation; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Chewing Gum; Clonidine; Critical Care; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Nurse's Role; Patient Education as Topic; Patient Selection; Phytotherapy; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Smoking Prevention; United States; United States Food and Drug Administration; Varenicline | 2006 |
Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations.
Topics: Administration, Cutaneous; Administration, Inhalation; Benzazepines; Bupropion; Chewing Gum; Clonidine; Coronary Artery Disease; Humans; Monoamine Oxidase Inhibitors; Nicotine; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Receptors, Nicotinic; Rimonabant; Selective Serotonin Reuptake Inhibitors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline | 2007 |
An update on therapeutics for tobacco dependence.
Topics: Alkaloids; Anti-Anxiety Agents; Azocines; Benzazepines; Bupropion; Clinical Trials as Topic; Databases, Bibliographic; Humans; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinolizines; Quinoxalines; Review Literature as Topic; Rimonabant; Smoking; Smoking Cessation; Varenicline | 2008 |
Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies.
Topics: Animals; Brain; Cannabinoid Receptor Modulators; Clinical Trials as Topic; Drug Evaluation, Preclinical; Emotions; Humans; Motivation; Nicotine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Secondary Prevention; Smoking Cessation; Tobacco Use Disorder | 2008 |
Novel pharmacological approaches for treating tobacco dependence and withdrawal: current status.
Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Clonidine; Cytochrome P-450 CYP2A6; Drug Delivery Systems; GABA Modulators; Humans; Narcotic Antagonists; Nicotine; Piperidines; Pyrazoles; Receptors, Nicotinic; Rimonabant; Substance Withdrawal Syndrome; Tobacco Use Disorder; Vaccination | 2008 |
Interventions for preventing weight gain after smoking cessation.
Topics: Antidepressive Agents; Benzazepines; Exercise; Female; Humans; Male; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Varenicline; Weight Gain | 2009 |
1 trial(s) available for nicotine and sr141716
Article | Year |
---|---|
A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Counseling; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Odds Ratio; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; Weight Gain; Young Adult | 2009 |
36 other study(ies) available for nicotine and sr141716
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats.
Topics: Animals; Brain Chemistry; Central Nervous System Depressants; Discrimination Learning; Dopamine; Ethanol; Extracellular Space; Male; Microdialysis; Motivation; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nucleus Accumbens; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Reinforcement, Psychology; Rimonabant; Self Administration | 2002 |
Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).
Topics: Acoustic Stimulation; Animals; Cues; Dopamine; Environment; Extinction, Psychological; Light; Male; Motivation; Motor Activity; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Self Administration; Substance Withdrawal Syndrome; Synaptic Transmission; Tobacco Use Disorder | 2005 |
Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences.
Topics: Animals; Behavior, Animal; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Interactions; Male; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Reinforcement, Psychology; Rimonabant | 2004 |
Suppression of conditioned nicotine and sucrose seeking by the cannabinoid-1 receptor antagonist SR141716A.
Topics: Animals; Behavior, Animal; Cannabinoid Receptor Antagonists; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Interactions; Extinction, Psychological; Inhibition, Psychological; Male; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Rimonabant; Sucrose; Sweetening Agents | 2005 |
Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats.
Topics: Animals; Association Learning; Conditioning, Psychological; Dose-Response Relationship, Drug; Injections, Subcutaneous; Male; Motivation; Nicotine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant | 2005 |
[Medication for ending tobacco dependency. Current state].
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cannabinoid Receptor Antagonists; Humans; Nicotine; Piperidines; Pyrazoles; Quinoxalines; Receptors, Nicotinic; Rimonabant; Smoking Cessation; Time Factors; Tobacco Use Disorder; Varenicline | 2005 |
Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice.
Topics: Animals; Arousal; Conditioning, Classical; Dose-Response Relationship, Drug; Dronabinol; Fear; Male; Maze Learning; Mice; Nicotine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant | 2006 |
Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats.
Topics: Animals; Association Learning; Autoradiography; Behavior, Animal; Benzoxazines; Binding, Competitive; Brain; Cannabinoid Receptor Modulators; Conditioning, Classical; Endocannabinoids; Guanosine 5'-O-(3-Thiotriphosphate); Male; Morpholines; Motivation; Motor Activity; Naphthalenes; Neuronal Plasticity; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Time Factors | 2006 |
WIN-55,212-2 and SR-141716A alter nicotine-induced changes in locomotor activity, but do not alter nicotine-evoked [3H]dopamine release.
Topics: Analgesics; Animals; Benzoxazines; Cannabinoid Receptor Antagonists; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Antagonism; In Vitro Techniques; Male; Morpholines; Motor Activity; Naphthalenes; Nicotine; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Tritium | 2007 |
The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol.
Topics: Alcohol-Induced Disorders, Nervous System; Alcoholism; Animals; Anxiety Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Synergism; Male; Maze Learning; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Reinforcement, Psychology; Rimonabant; Secondary Prevention; Substance Withdrawal Syndrome; Sucrose | 2007 |
Genetic and pharmacological approaches to evaluate the interaction between the cannabinoid and cholinergic systems in cognitive processes.
Topics: Animals; Avoidance Learning; Cognition; Male; Mice; Mice, Knockout; Nicotine; Physostigmine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Nicotinic; Rimonabant; Scopolamine | 2007 |
Cortico-limbic circuitry for conditioned nicotine-seeking behavior in rats involves endocannabinoid signaling.
Topics: Amygdala; Animals; Behavior, Addictive; Cannabinoid Receptor Modulators; Cerebral Cortex; Conditioning, Operant; Cues; Dose-Response Relationship, Drug; Endocannabinoids; Ganglionic Stimulants; Injections, Intravenous; Injections, Intraventricular; Limbic System; Male; Models, Anatomic; Motor Activity; Nicotine; Nucleus Accumbens; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Self Administration; Signal Transduction; Time Factors | 2007 |
Rimonabant blocks the expression but not the development of locomotor sensitization to nicotine in rats.
Topics: Analysis of Variance; Animals; Body Weight; Cues; Injections, Intraperitoneal; Male; Motor Activity; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Rimonabant | 2008 |
Smoking cessation 2008.
Topics: Benzazepines; Cannabinoid Receptor Antagonists; Drug Prescriptions; Humans; Marketing of Health Services; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking; Smoking Cessation; Smoking Prevention; Vaccines; Varenicline | 2008 |
The endogenous cannabinoid system modulates nicotine reward and dependence.
Topics: Animals; Cannabinoid Receptor Modulators; Conditioning, Psychological; Female; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Reward; Rimonabant; Signal Transduction; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |
Contextual renewal of nicotine seeking in rats and its suppression by the cannabinoid-1 receptor antagonist Rimonabant (SR141716A).
Topics: Analysis of Variance; Animals; Behavior, Animal; Cannabinoid Receptor Antagonists; Conditioning, Operant; Extinction, Psychological; Male; Nicotine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Reinforcement, Psychology; Rimonabant; Self Administration; Tobacco Use Disorder | 2008 |
Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors.
Topics: Amides; Amidohydrolases; Animals; Appetite Depressants; Arachidonic Acids; Benzamides; Cannabinoid Receptor Antagonists; Carbamates; Dopamine; Endocannabinoids; Enzyme Activation; Enzyme Inhibitors; Ethanolamines; Injections, Intraventricular; Lipoxygenase Inhibitors; Male; Neurons; Nicotine; Oleic Acids; Organ Culture Techniques; Palmitic Acids; Patch-Clamp Techniques; Piperidines; PPAR alpha; Protein-Tyrosine Kinases; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Rimonabant; Ventral Tegmental Area | 2008 |
The FAAH inhibitor URB-597 interferes with cisplatin- and nicotine-induced vomiting in the Suncus murinus (house musk shrew).
Topics: Amidohydrolases; Animals; Arachidonic Acids; Benzamides; Carbamates; Cisplatin; Drug Interactions; Endocannabinoids; Female; Male; Nicotine; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Shrews; Vomiting | 2009 |
Effects of rimonabant on the reinstatement of nicotine-conditioned place preference by drug priming in rats.
Topics: Analysis of Variance; Animals; Central Nervous System Agents; Conditioning, Classical; Extinction, Psychological; Male; Morphine; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Random Allocation; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Spatial Behavior | 2009 |
Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Hallucinogens; Male; Mice; Mice, Inbred C57BL; Nicotine; Phenylmethylsulfonyl Fluoride; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant | 2009 |
Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration--comparison with CB(1) receptor blockade.
Topics: Amidohydrolases; Animals; Behavior, Addictive; Benzamides; Carbamates; Enzyme Inhibitors; Male; Nicotine; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Rimonabant; Self Administration; Smoking | 2009 |
Investigation of endocannabinoid modulation of conditioned responding evoked by a nicotine CS and the Pavlovian stimulus effects of CP 55,940 in adult male rats.
Topics: Animals; Conditioning, Classical; Cyclohexanols; Discrimination Learning; Drug Interactions; Male; Nicotine; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant | 2009 |
[Current and future medical drugs for smoking cessation].
Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Cannabinoid Receptor Antagonists; Clinical Trials as Topic; Clonidine; Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Tobacco Use Disorder; Vaccines; Varenicline | 2009 |
Effects of the cannabinoid receptor ligands on anxiety-related effects of d-amphetamine and nicotine in the mouse elevated plus maze test.
Topics: Animals; Anxiety; Benzoxazines; Cannabinoid Receptor Agonists; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Interactions; Ligands; Male; Maze Learning; Mice; Morpholines; Naphthalenes; Nicotine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Cannabinoid; Rimonabant | 2009 |
Prosocial effects of nicotine and ethanol in adolescent rats through partially dissociable neurobehavioral mechanisms.
Topics: Aging; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Central Nervous System Depressants; Diazepam; Dopamine Antagonists; Ethanol; Exploratory Behavior; Flupenthixol; Locomotion; Male; Naloxone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Social Behavior | 2009 |
Current treatment options in smoking cessation.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Clonidine; Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Patient Selection; Piperidines; Practice Guidelines as Topic; Pyrazoles; Quinoxalines; Rimonabant; Self-Help Groups; Smoking Cessation; Tobacco Use Disorder; United States; Vaccines; Varenicline | 2010 |
Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.
Topics: Analgesics, Opioid; Animals; Behavior, Addictive; Behavior, Animal; Benzoxazines; Conditioning, Operant; Cues; Discrimination, Psychological; Dose-Response Relationship, Drug; Extinction, Psychological; Feeding Behavior; Male; Morpholines; Motivation; Motor Activity; Naphthalenes; Nicotine; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Reinforcement, Psychology; Rimonabant; Self Administration; Tobacco Use Disorder | 2012 |
Cannabinoid CB1 receptor antagonist rimonabant disrupts nicotine reward-associated memory in rats.
Topics: Animals; Avoidance Learning; Conditioning, Operant; Male; Memory; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Reward; Rimonabant | 2011 |
Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse.
Topics: Action Potentials; Analysis of Variance; Animals; Benzoxazines; Cannabinoids; Cocaine; Dopaminergic Neurons; Electric Stimulation; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Male; Morphine; Morpholines; Naloxone; Naphthalenes; Narcotic Antagonists; Narcotics; Neural Inhibition; Neural Pathways; Nicotine; Nicotinic Agonists; Patch-Clamp Techniques; Physical Stimulation; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Tegmentum Mesencephali; Time Factors; Ventral Tegmental Area | 2012 |
Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys.
Topics: Animals; Arachidonic Acids; Benzamides; Cannabinoid Receptor Antagonists; Carbamates; Cocaine; Dose-Response Relationship, Drug; Dronabinol; Drug-Seeking Behavior; Endocannabinoids; Male; Nicotine; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Reinforcement, Psychology; Reward; Rimonabant; Saimiri; Self Administration | 2016 |
Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Benzamides; Cannabinoid Receptor Antagonists; Carbamates; Cues; Drug-Seeking Behavior; Endocannabinoids; Male; Nicotine; Piperidines; Polyunsaturated Alkamides; PPAR alpha; Pyrazoles; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Tobacco Use Disorder | 2016 |
Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys.
Topics: Animals; Conditioning, Operant; Cues; Dronabinol; Drug-Seeking Behavior; Male; Marijuana Abuse; Nicotine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Recurrence; Reinforcement, Psychology; Rimonabant; Saimiri; Self Administration; Tobacco Use Disorder | 2016 |
CB
Topics: Animals; Arachidonic Acids; Brain; Cannabinoid Receptor Antagonists; Endocannabinoids; GABAergic Neurons; Glycerides; Male; Memory; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuronal Plasticity; Nicotine; Piperidines; Polyunsaturated Alkamides; Pyramidal Cells; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, GABA; Recognition, Psychology; Rimonabant; Substance Withdrawal Syndrome | 2017 |